M.R. Kramer

497 total citations
19 papers, 349 citations indexed

About

M.R. Kramer is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Transplantation. According to data from OpenAlex, M.R. Kramer has authored 19 papers receiving a total of 349 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Surgery, 7 papers in Pulmonary and Respiratory Medicine and 4 papers in Transplantation. Recurrent topics in M.R. Kramer's work include Transplantation: Methods and Outcomes (8 papers), Renal Transplantation Outcomes and Treatments (4 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers). M.R. Kramer is often cited by papers focused on Transplantation: Methods and Outcomes (8 papers), Renal Transplantation Outcomes and Treatments (4 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers). M.R. Kramer collaborates with scholars based in Israel, United States and Germany. M.R. Kramer's co-authors include Raj B. Uttamchandani, Margaret A. Fischl, Elizabeth C. George, Gordon M. Dickinson, Ashley Vo, Robert M. Kass, D. J. A. Ross, Michael I. Lewis, Elizabeth Fireman and Leonardo Fuks and has published in prestigious journals such as Clinical Infectious Diseases, CHEST Journal and Occupational and Environmental Medicine.

In The Last Decade

M.R. Kramer

19 papers receiving 341 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M.R. Kramer Israel 9 135 122 116 107 84 19 349
O A Aideyan Saudi Arabia 9 257 1.9× 125 1.0× 39 0.3× 35 0.3× 88 1.0× 10 418
R. Purgus France 8 70 0.5× 121 1.0× 53 0.5× 19 0.2× 42 0.5× 16 333
Christian Geltner Austria 17 270 2.0× 516 4.2× 17 0.1× 239 2.2× 48 0.6× 32 810
Salim B. Saab United States 9 123 0.9× 168 1.4× 19 0.2× 147 1.4× 28 0.3× 14 323
Jonathan Weber United States 10 52 0.4× 48 0.4× 21 0.2× 56 0.5× 14 0.2× 36 260
Goohyeon Hong South Korea 10 54 0.4× 123 1.0× 12 0.1× 114 1.1× 63 0.8× 26 301
PLC TISDALL Australia 12 174 1.3× 139 1.1× 26 0.2× 70 0.7× 56 0.7× 16 362
David Stenhouse United Kingdom 8 144 1.1× 43 0.4× 77 0.7× 22 0.2× 19 0.2× 16 330
José de Jesus Peixoto Camargo Brazil 13 166 1.2× 52 0.4× 4 0.0× 250 2.3× 4 0.0× 29 350
Juan Bravo Spain 9 46 0.3× 59 0.5× 11 0.1× 51 0.5× 5 0.1× 22 356

Countries citing papers authored by M.R. Kramer

Since Specialization
Citations

This map shows the geographic impact of M.R. Kramer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.R. Kramer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.R. Kramer more than expected).

Fields of papers citing papers by M.R. Kramer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.R. Kramer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.R. Kramer. The network helps show where M.R. Kramer may publish in the future.

Co-authorship network of co-authors of M.R. Kramer

This figure shows the co-authorship network connecting the top 25 collaborators of M.R. Kramer. A scholar is included among the top collaborators of M.R. Kramer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.R. Kramer. M.R. Kramer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Grubstein, Ahuva, et al.. (2021). Poor Outcomes of COVID-19 in Lung Transplant Recipients. Cohort Study in a Single Center. The Journal of Heart and Lung Transplantation. 40(4). S144–S144. 3 indexed citations
2.
Izhakian, Shimon, Walter G. Wasser, Benjamin D. Fox, et al.. (2016). Effectiveness of Rabbit Antithymocyte Globulin in Chronic Lung Allograft Dysfunction. Transplantation Proceedings. 48(6). 2152–2156. 12 indexed citations
3.
Shtraichman, Osnat, Paul D. Blanc, Jacob E. Ollech, et al.. (2015). Outbreak of autoimmune disease in silicosis linked to artificial stone. Occupational Medicine. 65(6). 444–450. 56 indexed citations
4.
Fireman, Elizabeth, Ohad Mazor, M.R. Kramer, Israel E. Priel, & Yehuda Lerman. (2009). Non-invasive diagnosis of chronic beryllium disease in workers exposed to hazardous dust in Israel. Occupational and Environmental Medicine. 67(9). 631–635. 7 indexed citations
5.
Shitrit, David, et al.. (2007). Quantitative Lung Perfusion Following Single Lung Transplantation. The Thoracic and Cardiovascular Surgeon. 55(1). 48–52. 15 indexed citations
6.
Shitrit, David, et al.. (2003). Tacrolimus-induced hemolytic uremic syndrome case presentation in a lung transplant recipient. Transplantation Proceedings. 35(2). 627–628. 9 indexed citations
7.
Berman, Marius, Tuvia Ben‐Gal, Alon Stamler, et al.. (2003). Lipid metabolism and immunosuppressive therapy in heart transplant recipients. Transplantation Proceedings. 35(2). 677–677. 4 indexed citations
8.
Izbicki, G, David Shitrit, Dan Aravot, et al.. (2002). Improved survival after lung transplantation in patients treated with tacrolimus/mycophenolate mofetil as compared with cyclosporine/azathioprine. Transplantation Proceedings. 34(8). 3258–3259. 5 indexed citations
9.
Schlüter, Hartmut & M.R. Kramer. (2001). [Epidemiological examples of infectious disease spread].. PubMed. 108(8). 338–43. 2 indexed citations
10.
Fink, Gershon, et al.. (2000). The sky is the limit: exercise capacity 10 years post-heart–lung transplantation. Transplantation Proceedings. 32(4). 733–734. 11 indexed citations
11.
Kramer, M.R., et al.. (1999). [When should a patient with severe acute respiratory distress syndrome (ARDS) be transferred to a specialized hospital?].. PubMed. 149(12). 345–51. 3 indexed citations
12.
Kramer, M.R., et al.. (1998). [Epidemiology, clinical aspects and prognosis of severe progressive community-acquired pneumonia].. PubMed. 52(5). 263–70. 3 indexed citations
13.
Ross, D. J. A., Michael I. Lewis, M.R. Kramer, Ashley Vo, & Robert M. Kass. (1997). FK 506 ‘Rescue’ Immunosuppression for Obliterative Bronchiolitis After Lung Transplantation. CHEST Journal. 112(5). 1175–1179. 48 indexed citations
14.
Wengrower, Dov, Eran Goldin, E. Kerem, & M.R. Kramer. (1997). Role of percutaneous endoscopic gastrostomy in a malnourished patient awaiting lung transplant. Transplantation Proceedings. 29(6). 2655–2656. 3 indexed citations
15.
Anteby, Irene, et al.. (1997). Necrotizing Choroiditis-Retinitis as Presenting Symptom of Disseminated Aspergillosis after Lung Transplantation. European Journal of Ophthalmology. 7(3). 294–296. 11 indexed citations
16.
Berkman, Neville, Mendel Glazer, Michael M. Friedlaender, et al.. (1997). Clustering of Pneumocystis carinii pneumonia in patients undergoing renal transplantation from living unrelated donors in Iraq and India.. PubMed. 33(3). 164–9. 6 indexed citations
17.
Berkman, Neville, et al.. (1995). Bilateral spontaneous pneumothorax as the presenting feature in lymphangioleiomyomatosis. Respiratory Medicine. 89(5). 381–383. 9 indexed citations
18.
Uttamchandani, Raj B., et al.. (1994). Nocardiosis in 30 Patients with Advanced Human Immunodeficiency Virus Infection: Clinical Features and Outcome. Clinical Infectious Diseases. 18(3). 348–353. 141 indexed citations
19.
Kramer, M.R., et al.. (1989). [Postmortem tissue embolisms. Report of 3 cases].. PubMed. 183(1-2). 29–36. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026